KalVista Pharmaceuticals, Inc.
DE ˙ DB ˙ US4834971032
23,01 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:4XC1 / KalVista Pharmaceuticals, Inc.
InstitutionMarshall Wace, Llp
Latest Disclosed Ownership162,908 shares
Latest Disclosed Value $ 3,279,339
Marshall Wace, Llp reports 56.06% decrease in ownership of 4XC1 / KalVista Pharmaceuticals, Inc.

On May 14, 2026 - Marshall Wace, Llp filed a 13F-HR form disclosing ownership of 162,908 shares of KalVista Pharmaceuticals, Inc. (DE:4XC1) valued at $2,525,074 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 13, 2025 disclosing 370,773 shares of KalVista Pharmaceuticals, Inc.. This represents a change in shares of -56.06% during the quarter. The current value of the position is $3,748,513 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F KALVISTA PHARMAC COMMON STOCK 483497103 162,908 -207,865 -56.06 3,279 -27.39 0.0033
2025-11-13 2025-09-30 13F KALVISTA PHARMAC COMMON STOCK 483497103 370,773 251,151 209.95 4,516 234.27 0.0046
2025-08-13 2025-06-30 13F KALVISTA PHARMAC COMMON STOCK 483497103 119,622 38,657 47.75 1,352 44.65 0.0015
2025-05-15 2025-03-31 13F KALVISTA PHARMAC COMMON STOCK 483497103 80,965 -37,013 -31.37 934 -6.51 0.0012
2025-02-13 2024-12-31 13F KALVISTA PHARMAC COMMON STOCK 483497103 117,978 103,072 691.48 999 480.81 0.0012
2024-11-14 2024-09-30 13F KALVISTA PHARMAC COMMON STOCK 483497103 14,906 -34,005 -69.52 173 -70.14 0.0002
2024-08-14 2024-06-30 13F KALVISTA PHARMAC COMMON STOCK 483497103 48,911 -579,976 -92.22 576 -92.28 0.0008
2024-05-15 2024-03-31 13F KALVISTA PHARMAC COMMON STOCK 483497103 628,887 628,887 7,459 0.0114
2024-02-14 2023-12-31 13F KALVISTA PHARMAC COMMON STOCK 483497103 0 -51,524 -100.00 0 -100.00
2023-11-14 2023-09-30 13F KALVISTA PHARMAC COMMON STOCK 483497103 51,524 51,524 496 0.0010
2023-05-15 2023-03-31 13F KALVISTA PHARMAC COMMON STOCK 483497103 0 -18,396 -100.00 0 -100.00
2023-02-14 2022-12-31 13F KALVISTA PHARMAC COMMON STOCK 483497103 18,396 18,396 124 0.0003
2022-11-14 2022-09-30 13F KALVISTA PHARMAC COMMON STOCK 483497103 0 -133,687 -100.00 0 -100.00
2022-08-15 2022-06-30 13F KALVISTA PHARMAC COMMON STOCK 483497103 133,687 97,328 267.69 1,316 145.52 0.0027
2022-05-16 2022-03-31 13F KALVISTA PHARMAC COMMON STOCK 483497103 36,359 36,359 536 0.0010
2021-11-15 2021-09-30 13F KALVISTA PHARMAC COMMON STOCK 483497103 0 -16,996 -100.00 0 -100.00
2021-08-13 2021-06-30 13F KALVISTA PHARMAC COMMON STOCK 483497103 16,996 -20,447 -54.61 407 -57.69 0.0020
2021-05-17 2021-03-31 13F KALVISTA PHARMAC COMMON STOCK 483497103 37,443 37,443 120.30 962 136.36 0.0044
2020-08-13 2020-06-30 13F KALVISTA PHARMAC COMMON STOCK 483497103 0 -18,454 -100.00 0 -100.00
2020-05-15 2020-03-31 13F KALVISTA PHARMAC COMMON STOCK 483497103 18,454 18,454 141 0.0014
2019-08-14 2019-06-30 13F KALVISTA PHARMAC COMMON STOCK 483497103 0 -29,452 -100.00 0 -100.00
2019-05-29 2019-03-31 13F/A-1 KALVISTA PHARMAC COMMON STOCK 483497103 29,452 29,452 843 0.0079
2019-05-14 2019-03-31 13F KALVISTA PHARMAC COMMON STOCK 483497103 29,452 843 0.0080
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.